- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/015 - Antigènes d'Hemosporidia, p.ex. antigènes de Plasmodium
Détention brevets de la classe A61K 39/015
Brevets de cette classe: 637
Historique des publications depuis 10 ans
|
44
|
50
|
51
|
34
|
46
|
41
|
28
|
27
|
43
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1698 |
25 |
| Oxford University Innovation Limited | 1492 |
20 |
| Institut Pasteur | 789 |
19 |
| Sanaria Inc. | 35 |
19 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
18 |
| Artificial Cell Technologies, Inc. | 38 |
15 |
| The United States of America as represented by the Secretary of the Navy | 2722 |
10 |
| Isis Innovation Limited | 514 |
10 |
| Leidos, Inc. | 203 |
10 |
| The Trustees of the University of Pennsylvania | 4254 |
9 |
| Seattle Children's Hospital, d/b/a Seattle Children's Research Institute | 115 |
9 |
| The United States of America as represented by the Secretary of the Army | 1180 |
8 |
| GenVec, Inc. | 59 |
8 |
| Griffith University | 154 |
8 |
| Rhode Island Hospital | 191 |
8 |
| University of Washington | 2250 |
8 |
| Board of Trustees of the University of Arkansas | 785 |
7 |
| Modernatx, Inc. | 1205 |
7 |
| The Texas a & M University System | 1596 |
7 |
| The Walter and Eliza Hall Institute of Medical Research | 170 |
7 |
| Autres propriétaires | 405 |